Visit Digital Exhibition Stand

We are grateful to our sponsors for their support of this meeting. Please visit their digital stands for further information about their products. Our sponsors’ representatives will be delighted to meet symposium participants via breakout rooms during break hours. If you are interested, please send your name and email address to Breakout rooms are open to registered meeting delegates only.

SomaLogic is transforming healthcare by applying our proprietary protein-measurement technology to enable the precise monitoring of each individual’s health and wellness status in real time. We work with many different partners across research, health management, pharmaceutical development, and other health-related fields to build applications on our “SomaScan® Platform,” a single cost-effective and reliable testing platform that provides actionable and timely information to patients and healthcare providers across a wide range of diseases and conditions. Our SOMAmer® and SomaScan technologies also have multiple applications across the biomedical and life sciences, and are currently available to the entire scientific community for their own research needs. For more information, visit

Visit Digital Stand

Pure Biologics  S.A. is one of the largest Polish biotech companies. Founded in 2010, it is listed on the NewConnect market of the Warsaw Stock Exchange.

Pure Biologics’ major R&D activity focuses on bispecific and fusion antibodies, as well as aptamers to be developed into viable candidates for therapeutics in immunooncology (colorectal, breast and lung cancers), and in the treatment of neurological diseases (neuromyelitis optica, myasthenia gravis).

To this end, Pure Biologics has created highly efficient platforms to generate specific antibodies and modified aptamers, supported by state-of-the-art assays and analytics. Moreover, Pure Biologics utilizes its broad experience in antibodies, aptamers, cell and molecular biology, protein and antigen expression and purification, custom assay development, and ligand-binding analysis, offering complex solutions not only as a contract research organization and service provider, but primarily as a professional consultant and R&D partner. Its customers represent a wide variety of environments, ranging from academic collaborations to pharma and biotech companies. Pure Biologics aims to out-license its early-stage assets and to connect with partners in need of complex biotechnological solutions.

Visit Digital Stand

From the everyday consumer to scientists in the laboratory, we all rely on accurate information to make critical decisions. Waters Corporation is the world’s leading specialty measurement company focused on improving human health and well-being through the application of high-value analytical technologies and industry leading scientific expertise.

Our decisions and actions are guided by two simple words – Deliver Benefit. Our founder, Jim Waters, coined these words to encapsulate the idea that we should positively impact our customers, employees, shareholders and society at every opportunity.

Driven by that ethos for over sixty years, Waters has continually pioneered chromatography, mass spectrometry and thermal analysis innovations. Whether it’s discovering new pharmaceuticals, assuring the safety of the world’s food and water supplies, or ensuring the integrity of a chemical entity in production, we are constantly working with our 40,000+ customers to change the world.

Waters solutions can help you to obtain superior analytical data for oligonucleotides and aptamers, from routine mass and sequence confirmation to more detailed impurity profiling

By combining ACQUITY UPLC instrument technology, industry leading Oligo Separation Technology (OST) columns, pre-validated MassPrep OST reference standard and a range of Mass Spectrometry systems, Waters brings an unrivalled level of performance for oligonucleotide, peptide and aptamer analysis.

Visit Digital Stand


Download PDF Documents Password protected 

Important Deadlines

Early Registration: 17 Jul 2020
Standard Registration: 28 Aug 2020
Oral Abstracts: Closed
Poster Abstracts: 14 Aug 2020
Digital Posters: 28 Aug 2020

Join our emailing list
Please wait...